Guest
Guest
Jun 12, 2025
2:36 AM
|
Vidalista 2.5 mg contains Tadalafil, a medication that treats erectile dysfunction by targeting the biochemical pathways involved in erection. One key molecule involved in this process is cyclic guanosine monophosphate (cGMP), a compound that helps relax the smooth muscles in the blood vessels of the penis, allowing increased blood flow and leading to an erection.
Normally, during sexual stimulation, the body releases nitric oxide (NO) in the penis, which stimulates the production of cGMP. This cGMP causes the smooth muscles around the penile arteries to relax, allowing blood to fill the erectile tissue. However, an enzyme called phosphodiesterase type 5 (PDE5) breaks down cGMP, which can reduce blood flow and lead to difficulties in maintaining an erection.
VIDALISTA 2.5 MG works by inhibiting the PDE5 enzyme, preventing it from breaking down cGMP. As a result, cGMP levels remain elevated for longer periods, promoting sustained relaxation of the blood vessels and improving erectile function. Although the 2.5 mg dose is relatively low, it still effectively supports this mechanism, making it suitable for daily use in men who need continuous management of erectile dysfunction.
By maintaining higher cGMP levels, Vidalista 2.5 mg helps improve blood flow and enhances the ability to achieve and sustain an erection during sexual activity.
|
